Patient information: uses, side effects, how to take - Dexamethasone Injection
INSTRUCTIONS FOR USE
Figure 1: Outer Packaging and Prefilled Syringe
NOTES:
Do not introduce any other fluid into the syringe at any time.
Do not dilute for IV push.
Do not re-sterilize the syringe.
Do not use this product on a sterile field.
This product is for single dose only.
1. Inspect the outer packaging (blister pack) to confirm the integrity of the packaging. Do not use if the blister pack or the prefilled syringe has been damaged.
2. Remove the syringe from the outer packaging. (See Figure 2)
Figure 2
3. Visually inspect the syringe. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
4. Twist off the syringe tip cap. Do not remove the label around the luer lock collar. (See Figure 3)
Figure 3
5. Expel air bubble(s). Adjust the dose (if applicable).
6. Administer the dose ensuring that pressure is maintained on the plunger rod during the entire administration.
7. Discard the used syringe into an appropriate receptacle.
For more information concerning this drug, please call Fresenius Kabi USA, LLC at 1-800-551-7176.
To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC at 1-800-551-7176 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
The brand names mentioned in this document are the trademarks of their respective owners.
ANDA 203129Abbreviated New Drug Application (ANDA) – generic drug
Approved September 30, 2015
Therapeutic equivalence (TE) code
APCodes starting with A mean the FDA rates the drug therapeutically equivalent to its reference drug (Orange Book).
Manufacturers
13 labelers list this drug on DailyMed
Drug shortage
Current since November 3, 2026
Recalls
February 4, 2026: Class II recall: Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.
Packages (NDC)
Package
4 mg/mL – 1.00 ml in 1 syringe, glass / 1 in 1 blister pack / 24 in 1 carton
Source: FDA drug labeling via NLM DailyMed, data as of November 5, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.